Archive
Volume 2, Issue 1, 2026 March
2(1), 2026 March
Original article
Highlight Mediterr J Med Med Sci, vol.2 n1, 1-9, March, 2026, Publication date December 19, 2025 Systemic onset juvenile idiopathic arthritis a single-center experience at Tripoli Children's Hospital, Libya
Arthritis, juvenile rheumatoid, Libya, MAS, Rheumatology
Original articleRhematology
Commentary
Highlight https://doi.org/10.5281/zenodo.18310351
Mediterr J Med Med Sci, vol.2 n1, 9-12, March, 2026, Publication date January 20, 2026 First-in-class non-opioid analgesics: Molecular mechanisms and clinical impact of suzetrigine Analgesic, clinical effect, NaV1.8 sodium channel, pain, suzetrigine CommentaryPharmacology
Mediterr J Med Med Sci, vol.2 n1, 9-12, March, 2026, Publication date January 20, 2026 First-in-class non-opioid analgesics: Molecular mechanisms and clinical impact of suzetrigine Analgesic, clinical effect, NaV1.8 sodium channel, pain, suzetrigine CommentaryPharmacology
Highlight https://doi.org/10.5281/zenodo.18651656
Mediterr J Med Med Sci, vol.2 n1, 36-39, March, 2026, Publication date February 15, 2026 Long-term use of proton pump inhibitors: Possible unwanted effects and mitigation strategies B12 deficiency, gastrointestinal disorders, long-term use, PPI, unwanted effects CommentaryPharmacology
Mediterr J Med Med Sci, vol.2 n1, 36-39, March, 2026, Publication date February 15, 2026 Long-term use of proton pump inhibitors: Possible unwanted effects and mitigation strategies B12 deficiency, gastrointestinal disorders, long-term use, PPI, unwanted effects CommentaryPharmacology
Perspective
Highlight https://doi.org/10.5281/zenodo.18407685
Mediterr J Med Med Sci, vol.2 n1, 13-18, March, 2026, Publication date January 26, 2026 Targeting mitochondrial function through clinical foods: Emerging strategies for metabolic diseases Mitochondrial dysfunction, gut-mitochondria axis, nutrients, stress, ATP PerspectiveMolecular biology
Mediterr J Med Med Sci, vol.2 n1, 13-18, March, 2026, Publication date January 26, 2026 Targeting mitochondrial function through clinical foods: Emerging strategies for metabolic diseases Mitochondrial dysfunction, gut-mitochondria axis, nutrients, stress, ATP PerspectiveMolecular biology
Highlight https://doi.org/10.5281/zenodo.18772947
Mediterr J Med Med Sci, vol.2 n1, 51-58, March, 2026, Publication date February 25, 2026 Ethical and legal challenges of Artificial Intelligence-based medical diagnostics: A perspective Accountability, algorithmic bias, governance, medical diagnostic PerspectiveMedicine
Mediterr J Med Med Sci, vol.2 n1, 51-58, March, 2026, Publication date February 25, 2026 Ethical and legal challenges of Artificial Intelligence-based medical diagnostics: A perspective Accountability, algorithmic bias, governance, medical diagnostic PerspectiveMedicine
Case report
Highlight https://doi.org/10.5281/zenodo.18407734
Mediterr J Med Med Sci, vol.2 n1, 19-20, March, 2026, Publication date January 28, 2026 Colistin use in the Neonatal Intensive Care Unit of Algala Maternity Hospital Antibiotic, bacterial infection, Gram-negative bacteria, Libya, polymyxin Case reportClinical Pharmacy
Mediterr J Med Med Sci, vol.2 n1, 19-20, March, 2026, Publication date January 28, 2026 Colistin use in the Neonatal Intensive Care Unit of Algala Maternity Hospital Antibiotic, bacterial infection, Gram-negative bacteria, Libya, polymyxin Case reportClinical Pharmacy
Highlight https://doi.org/10.5281/zenodo.18987510
Mediterr J Med Med Sci, vol.2 n1, 59-65, March, 2026, Publication date March 12, 2026 Action of Regenerator Cel gel (acetyl dressing/antiseptic) and Remotis solution (acetyl dressing/antiseptic) in the treatment of wounds Burn, genetic engineering, melanoma, wound healing Case reportMedicine
Mediterr J Med Med Sci, vol.2 n1, 59-65, March, 2026, Publication date March 12, 2026 Action of Regenerator Cel gel (acetyl dressing/antiseptic) and Remotis solution (acetyl dressing/antiseptic) in the treatment of wounds Burn, genetic engineering, melanoma, wound healing Case reportMedicine
Review
Highlight https://doi.org/10.5281/zenodo.18444760
Mediterr J Med Med Sci, vol.2 n1, 21-27, March, 2026, Publication date January 31, 2026 From one-size-fits-all to tailor-made: The emergence of personalized medicine in clinical practice Biomarkers, genomic medicine, microbiome, pharmacogenomics, precision medicine ReviewMedicine
Mediterr J Med Med Sci, vol.2 n1, 21-27, March, 2026, Publication date January 31, 2026 From one-size-fits-all to tailor-made: The emergence of personalized medicine in clinical practice Biomarkers, genomic medicine, microbiome, pharmacogenomics, precision medicine ReviewMedicine
Short communication
Highlight https://doi.org/10.5281/zenodo.18636582
Mediterr J Med Med Sci, vol.2 n1, 28-35, March, 2026, Publication date February 13, 2026 Chemical compositions, nutritional values, total phenolic content, and antioxidant activity from Eleocharis dulcis Antioxidant, DPPH, Folin-Ciocalteau, nutritional, phytochemicals Short communicationPharmacology
Mediterr J Med Med Sci, vol.2 n1, 28-35, March, 2026, Publication date February 13, 2026 Chemical compositions, nutritional values, total phenolic content, and antioxidant activity from Eleocharis dulcis Antioxidant, DPPH, Folin-Ciocalteau, nutritional, phytochemicals Short communicationPharmacology
Highlight https://doi.org/10.5281/zenodo.18667523
Mediterr J Med Med Sci, vol.2 n1, 40-50, March, 2026, Publication date February 17, 2026 Immune profile score of modified Tremelimumab with CTLA-4 could enhance immunotherapy using molecular docking Antitumor immune responses, docking, CTLA-4, epigenetic, genetic, Tremelimumab Short communicationMolecular biology
Mediterr J Med Med Sci, vol.2 n1, 40-50, March, 2026, Publication date February 17, 2026 Immune profile score of modified Tremelimumab with CTLA-4 could enhance immunotherapy using molecular docking Antitumor immune responses, docking, CTLA-4, epigenetic, genetic, Tremelimumab Short communicationMolecular biology
